vs
Side-by-side financial comparison of Golden Matrix Group, Inc. (GMGI) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $49.6M, roughly 1.5× Golden Matrix Group, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -15.8%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $6.4M). Over the past eight quarters, Golden Matrix Group, Inc.'s revenue compounded faster (104.6% CAGR vs 31.3%).
Golden Matrix Group Inc. is a global gaming tech firm that develops and licenses proprietary online gaming platforms, social casino products and interactive solutions. It serves B2B gaming operator clients across North America, Europe and Asia-Pacific, plus runs direct-to-consumer casual gaming properties.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
GMGI vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $49.6M | $75.5M |
| Net Profit | $-88.7M | — |
| Gross Margin | 57.5% | 69.3% |
| Operating Margin | -188.3% | 22.7% |
| Net Margin | -179.0% | — |
| Revenue YoY | -15.8% | 27.7% |
| Net Profit YoY | -4880.1% | — |
| EPS (diluted) | $-7.73 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $49.6M | $75.5M | ||
| Q3 25 | $47.3M | $54.5M | ||
| Q2 25 | $43.2M | $52.4M | ||
| Q1 25 | $42.7M | $46.0M | ||
| Q4 24 | $58.9M | $59.1M | ||
| Q3 24 | $41.0M | $80.5M | ||
| Q2 24 | $39.4M | $47.1M | ||
| Q1 24 | $11.8M | $43.8M |
| Q4 25 | $-88.7M | — | ||
| Q3 25 | $566.0K | $8.8M | ||
| Q2 25 | $-3.6M | $5.9M | ||
| Q1 25 | $-231.6K | $3.0M | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | $-3.4M | $20.3M | ||
| Q2 24 | $64.9K | $-4.5M | ||
| Q1 24 | $74.5K | $-4.8M |
| Q4 25 | 57.5% | 69.3% | ||
| Q3 25 | 55.8% | 77.7% | ||
| Q2 25 | 56.4% | 76.5% | ||
| Q1 25 | 56.6% | 77.1% | ||
| Q4 24 | 69.8% | 76.4% | ||
| Q3 24 | 54.7% | 63.9% | ||
| Q2 24 | 55.0% | 77.4% | ||
| Q1 24 | 28.5% | 75.5% |
| Q4 25 | -188.3% | 22.7% | ||
| Q3 25 | -0.8% | 17.6% | ||
| Q2 25 | -5.3% | 12.7% | ||
| Q1 25 | -0.2% | 8.7% | ||
| Q4 24 | 5.6% | 22.6% | ||
| Q3 24 | -2.4% | 27.4% | ||
| Q2 24 | 0.3% | -4.6% | ||
| Q1 24 | 2.4% | -5.3% |
| Q4 25 | -179.0% | — | ||
| Q3 25 | 1.2% | 16.2% | ||
| Q2 25 | -8.3% | 11.2% | ||
| Q1 25 | -0.5% | 6.5% | ||
| Q4 24 | 3.2% | — | ||
| Q3 24 | -8.3% | 25.2% | ||
| Q2 24 | 0.2% | -9.6% | ||
| Q1 24 | 0.6% | -11.0% |
| Q4 25 | $-7.73 | $0.26 | ||
| Q3 25 | $0.00 | $0.17 | ||
| Q2 25 | $-0.03 | $0.12 | ||
| Q1 25 | $0.00 | $0.06 | ||
| Q4 24 | $-0.13 | $0.40 | ||
| Q3 24 | $-0.03 | $0.41 | ||
| Q2 24 | $0.00 | $-0.09 | ||
| Q1 24 | $0.00 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $46.5M | $130.3M |
| Total Assets | $118.1M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $46.5M | $130.3M | ||
| Q3 25 | $123.5M | $115.3M | ||
| Q2 25 | $121.3M | $104.7M | ||
| Q1 25 | $108.5M | $97.1M | ||
| Q4 24 | $105.1M | $92.1M | ||
| Q3 24 | $94.3M | $71.1M | ||
| Q2 24 | $90.4M | $48.5M | ||
| Q1 24 | $32.1M | $51.0M |
| Q4 25 | $118.1M | $216.3M | ||
| Q3 25 | $209.8M | $202.9M | ||
| Q2 25 | $210.3M | $194.9M | ||
| Q1 25 | $214.0M | $196.2M | ||
| Q4 24 | $213.7M | $213.3M | ||
| Q3 24 | $213.5M | $220.7M | ||
| Q2 24 | $191.5M | $205.0M | ||
| Q1 24 | $37.1M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $14.4M |
| Free Cash FlowOCF − Capex | $6.4M | $14.4M |
| FCF MarginFCF / Revenue | 13.0% | 19.1% |
| Capex IntensityCapex / Revenue | 3.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $19.2M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $14.4M | ||
| Q3 25 | $7.0M | $9.7M | ||
| Q2 25 | $2.4M | $14.1M | ||
| Q1 25 | $7.7M | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | $4.8M | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | $8.2K | $11.2M |
| Q4 25 | $6.4M | $14.4M | ||
| Q3 25 | $6.2M | $9.7M | ||
| Q2 25 | $-89.4K | $14.1M | ||
| Q1 25 | $6.6M | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | $2.3M | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | $6.7K | — |
| Q4 25 | 13.0% | 19.1% | ||
| Q3 25 | 13.1% | 17.7% | ||
| Q2 25 | -0.2% | 26.8% | ||
| Q1 25 | 15.5% | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | 5.6% | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | 0.1% | — |
| Q4 25 | 3.6% | 0.0% | ||
| Q3 25 | 1.8% | 0.0% | ||
| Q2 25 | 5.7% | 0.0% | ||
| Q1 25 | 2.6% | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 6.0% | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | 0.0% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 12.42× | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.11× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GMGI
| R Kings And CFAC | $43.8M | 88% |
| Other | $5.8M | 12% |
PBYI
Segment breakdown not available.